Page last updated: 2024-08-23

raloxifene hydrochloride and Adenohypophyseal Hyposecretion

raloxifene hydrochloride has been researched along with Adenohypophyseal Hyposecretion in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birzniece, V; Frystyk, J; Ho, KK; Magnusson, NE	1
Baxter, RC; Birzniece, V; Gibney, J; Ho, KK; Johannsson, G; Meinhardt, U; Seibel, MJ	1
Armstrong, N; Baxter, RC; Birzniece, V; Gibney, J; Ho, KK; Johannsson, G; Meinhardt, UJ	1
Matsuno, A; Okazaki, R; Okinaga, H	1

Trials

3 trial(s) available for raloxifene hydrochloride and Adenohypophyseal Hyposecretion

Article	Year
Effects of raloxifene and estrogen on bioactive IGF1 in GH-deficient women. European journal of endocrinology, 2014, Volume: 170, Issue:3 Topics: Adult; Estradiol; Female; HEK293 Cells; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Middle Aged; Raloxifene Hydrochloride	2014
Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:5 Topics: Adult; Calorimetry, Indirect; Cross-Over Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leucine; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2010
Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women. The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:3 Topics: Adult; Body Composition; Bone Density; Cross-Over Studies; Estradiol; Female; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hypopituitarism; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome	2012

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Adenohypophyseal Hyposecretion

Article	Year
High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions. Endocrine journal, 2005, Volume: 52, Issue:6 Topics: Adolescent; Adult; Aged; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Child; Collagen; Collagen Type I; Craniopharyngioma; Diphosphonates; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hydrocortisone; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Peptides; Pituitary Neoplasms; Raloxifene Hydrochloride; Risk Factors; Testosterone; Thyroxine	2005

Article

Year

High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions.

Endocrine journal, 2005, Volume: 52, Issue:6

Topics: Adolescent; Adult; Aged; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Child; Collagen; Collagen Type I; Craniopharyngioma; Diphosphonates; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hydrocortisone; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Peptides; Pituitary Neoplasms; Raloxifene Hydrochloride; Risk Factors; Testosterone; Thyroxine

2005